- $239.65m
- $39.63m
- 51
- 37
- 83
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 44 | 18.4 | 4.01 | 0 |
Cost of Revenue | |||||
Gross Profit | — | 9.45 | 12.6 | 3.36 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | -719 | 62.3 | 43.5 | 38.5 | 37.5 |
Operating Profit | 719 | -18.3 | -25.1 | -34.5 | -37.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 718 | -12.8 | -25.5 | -33.6 | -24.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 669 | -11.2 | -17.4 | -32.9 | -24.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 669 | -11.2 | -17.4 | -32.9 | -24.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 669 | -11.2 | -17.4 | -32.9 | -24.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.91 | -0.364 | -0.58 | -1.08 | -0.807 |
Special Dividends per Share |